International Virtual Meet on Tissue Science, Stem Cells and Regenerative Medicine “Tissue Science Webinars” is scheduled on May 24-25, 2021 to bring together unique and international mix of experts to exchange and share their experiences and research outcomes on all elements of Tissue Science and Regenerative Medicine.
We welcome Tissue Science and Regenerative Medicine Associations and Societies, Business Delegates, CEO’s and R&D Heads from Industries, Tissue Researchers, Global Tissue Science and Regenerative Medicine Organizations, Associations and Foundations, Tissue Science and Regenerative Medicine Investors, Exhibitors and Sponsors, Doctors, Plastic surgeons, Biomedicine Researchers, Biotechnologists, Nanotechnologists, Stem Cell Laboratory, Technicians, Biomedical Engineers , Stem Cell Professors, Faculties, Researchers and Students from Academia in the study of Tissue Science, Tissue engineering, Stem cells and Regenerative Medicine
The Americas is expected to dominate the market, mainly due to the increasing geriatric population and the availability of advanced healthcare facilities in this region. Factors leading to the growth of tissue engineering market are increasing the number of clinical trials to evaluate the therapeutic potential of products
Europe is anticipated to account for the second-largest market share during the forecast period. Factors responsible for market growth in this region are high availability of funds for R&D, and rising support of the government for the life science domain
Asia-Pacific is estimated to be the fastest-growing region in the global tissue engineering market due to the rising biomaterial-based research, increasing demand for plastic surgeries, growing cancer incidence, and the increasing prevalence of cardiovascular diseases. Japan held a market share of 25.3% in 2018
The tissue engineering market in the Middle East & Africa accounts for the least share in the during the forecast period. The market is expected to dominate due to the increasing use of tissue engineering for the treatment of various chronic diseases in Saudi Arabia, Kuwait, and the UAE